Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years

Author： Ceci A.   Felisi M.   Baiardi P.   Bonifazi F.   Catapano M.   Giaquinto C.   Nicolosi A.   Sturkenboom M.   Neubert A.   Wong I.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.11, 2006-11, pp. : 947-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance

By Permanand Govin   Mossialos Elias   McKee Martin  

Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. : 87-90

Royal College Of Physicians

Access to resources Recommend Favorite

The European Medicines Agency Discovers the Geriatric Patient

By Baeyens JP  

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 849-851

Adis International

Access to resources Recommend Favorite

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

By Peter Kasper  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 221-223

Adis International

Access to resources Recommend Favorite

Striking a balance: concerted action for children's medicines

By Crawley F.   Smith R.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 1, 2002-02 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

The European Medicines Agency has announced they will be making important changes.

By  

Reactions Weekly, Vol. 1, Iss. 1282, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite